Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$602,901
+$455 QoQ
Shares Held
3,847
-2.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#808
of 1,603 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURKE & HERBERT BANK & TRUST CO holds $27,845,338 across 9 Drug Manufacturers - General names. NVS ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
39,190 | $9,953,084 | |
| 2 | LLY |
ELI LILLY & Co
|
5,231 | $6,274,217 | |
| 3 | ABBV |
AbbVie Inc.
|
20,061 | $5,048,149 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,309 | $2,609,706 | |
| 5 | PFE |
Pfizer Inc
|
67,288 | $1,620,294 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,041 | $751,422 | |
| 7 | NVS |
Novartis AG
This page
|
3,847 | $602,901 | |
| 8 | AMGN |
Amgen Inc
|
1,593 | $576,856 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $602,901 | 3,847 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $602,446 | 3,944 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $543,759 | 3,944 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $468,588 | 3,654 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $442,170 | 3,654 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $407,347 | 3,654 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $355,570 | 3,654 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $420,283 | 3,654 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $389,004 | 3,654 | Shares | Sole | 2024-07-16 | |
| No filing history on record for this holder in this stock. | ||||||